CVF Technologies Corporation (CNVT)

Market Cap	4.09K
Revenue (ttm)	957.43K
Net Income (ttm)	-3.34M
Shares Out	40.88M
EPS (ttm)	-0.26
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,000
Average Volume	100,563
Open	0.0001
Previous Close	0.0350
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0850
Beta	8.16
RSI	40.05
Earnings Date	n/a

About Intra-Cellular Therapies

CVF Technologies Corporation engages in the investment, development, and management of early stage private companies that operate in the environmental technology sector in the United States and Canada. The company, through its interests in Xylodyne Corporation, develops proprietary technology relating to electric vehicles. CVF Technologies, through its subsidiary, Ecoval Corporation, involves in the development, manufacture, and marketing of organic herbicides, insecticides, and tree recovery systems primarily for the lawn and garden retail/con...

• Industry: Consulting Services
• Sector: Industrials
• Founded: 1989
• Employees: 9
• Stock Exchange: OTCMKTS
• Ticker Symbol: CNVT

Financial Performance

In 2007, CVF Technologies's revenue was $1.98 million, an increase of 30.70% compared to the previous year's $1.51 million. Losses were -$2.09 million, 13.0% more than in 2006.